• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A note on the use of influenza vaccination strategies when supply is limited

tetano

Editor, Senior Moderator
Math Biosci Eng. 2011 Jan 1;8(1):171-82. doi: 10.3934/mbe.2011.8.171.
A note on the use of influenza vaccination strategies when supply is limited.

Lee S, Morales R, Castillo-Chavez C.

Mathematical, Computational and Modeling Sciences Center, School of Human Evolution and Social Change, Arizona State University, Tempe, AZ 85287, United States. slee221@asu.edu.
Abstract

The 2009 A (H1N1) influenza pandemic was rather atypical. It began in North America at the start of the spring and in the following months, as it moved south, efforts to develop a vaccine that would mitigate the potential impact of a second wave were accelerated. The world's limited capacity to produce an adequate vaccine supply over just a few months resulted in the development of public health policies that "had" to optimize the utilization of limited vaccine supplies. Furthermore, even after the vaccine was in production, extensive delays in vaccine distribution were experienced for various reasons. In this note, we use optimal control theory to explore the impact of some of the constraints faced by most nations in implementing a public health policy that tried to meet the challenges that come from having access only to a limited vaccine supply that is never 100% effective.

PMID: 21361406 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/21361406
 
Back
Top Bottom